Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

ReNeuron Group plc.

John D Sinden1

  • 1ReNeuron Group plc, Surrey Research Park, Guildford, UK. John-Sinden@reneuron.com

Regenerative Medicine
|May 1, 2007
PubMed
Summary
This summary is machine-generated.

ReNeuron pioneers stem cell therapies to reverse major diseases. Their proprietary technology focuses on treatments for stroke, diabetes, and eye conditions.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Implantation of the clinical-grade human neural stem cell line, CTX0E03, rescues the behavioral and pathological deficits in the quinolinic acid-lesioned rodent model of Huntington's disease.

Stem cells (Dayton, Ohio)·2020
Same author

Generation of c-MycER<sup>TAM</sup>-transduced human late-adherent olfactory mucosa cells for potential regenerative applications.

Scientific reports·2019
Same author

Human Neural Stem Cell Therapy for Chronic Ischemic Stroke: Charting Progress from Laboratory to Patients.

Stem cells and development·2017
Same author

Investigation of Content, Stoichiometry and Transfer of miRNA from Human Neural Stem Cell Line Derived Exosomes.

PloS one·2016
Same author

Characterization of lipid metabolism in a novel immortalized human hepatocyte cell line.

American journal of physiology. Endocrinology and metabolism·2015
Same author

Differentiation of a Human Neural Stem Cell Line on Three Dimensional Cultures, Analysis of MicroRNA and Putative Target Genes.

Journal of visualized experiments : JoVE·2015
Same journal

Industry updates in advanced therapy medicinal products and regenerative medicine - May 2026.

Regenerative medicine·2026
Same journal

Ethical, legal, and social issues associated with human fetal tissue research in Japan.

Regenerative medicine·2026
Same journal

The future of hematopoietic stem cell and stem cell gene therapy for metabolic diseases.

Regenerative medicine·2026
Same journal

Exploring gene therapy for developmental and epileptic encephalopathies (DEEs): possibilities or promises?

Regenerative medicine·2026
Same journal

Industry updates in advanced therapy medicinal products and regenerative medicine - April 2026.

Regenerative medicine·2026
Same journal

Optimizing strategies in tendon tissue engineering through effective scaffold design: overview of recent advancements.

Regenerative medicine·2026
See all related articles

Area of Science:

  • Biotechnology
  • Regenerative Medicine
  • Stem Cell Biology

Background:

  • ReNeuron is a UK-based company specializing in stem cell research and development.
  • The company possesses advanced, proprietary somatic stem cell technologies.

Purpose of the Study:

  • To develop innovative cell therapy products.
  • To create treatments aimed at reversing the effects of debilitating diseases.

Main Methods:

  • Utilizing proprietary somatic stem cell technologies.
  • Focusing on therapeutic applications for major diseases.

Main Results:

  • Development of groundbreaking cell therapy products.
  • Potential to reverse the effects of stroke, diabetes, and eye diseases.

Conclusions:

  • ReNeuron's stem cell technology holds promise for treating major diseases.
  • The company is at the forefront of developing novel cell therapies.